DAVID P WITTE, M.D.
Medical Practice in Cincinnati, OH
License number
Ohio 35.051428
Category
Medical Practice
Type
Pediatric Pathology
Address
Address
3333 Burnet Ave Ml, Cincinnati, OH 45229
Phone
(513) 636-4261
(513) 636-3924 (Fax)
(513) 636-3924 (Fax)
Personal information
See more information about DAVID P WITTE at radaris.comName
Address
Phone
5631 County Road 11, Wauseon, OH 43567
6039 Ramblingridge Dr, Cincinnati, OH 45247
5810 W Us Highway 6, Helena, OH 43435
4162 Sherman Rd, Norton, OH 44203
861 N Main St, Gibsonburg, OH 43431
Professional information
Director At Cincinnati Childrens Hospital Medical Center
Position:
Director at Cincinnati Childrens Hospital Medical Center
Location:
Cincinnati Area
Industry:
Hospital & Health Care
Work:
Cincinnati Childrens Hospital Medical Center
-
Director
David Paul Witte, Cincinnati OH
Specialties:
Pathology, Anatomic Pathology, Pediatric Pathology
Work:
Cincinnati Children's Hospital Medical Center
3333 Burnet Ave, Cincinnati, OH 45267 Academic Pathology Associates Inc.
231 Albert Sabin Way, Cincinnati, OH 45267
3333 Burnet Ave, Cincinnati, OH 45267 Academic Pathology Associates Inc.
231 Albert Sabin Way, Cincinnati, OH 45267
Education:
University of Cincinnati (1979)
Dr. David P Witte, Cincinnati OH - MD (Doctor of Medicine)
Specialties:
Pediatric Pathology
Address:
Children's Hos Med Ctr Patholo
3333 Burnet Ave SUITE 1035, Cincinnati 45229
(513) 636-4261 (Phone)
3333 Burnet Ave SUITE 1035, Cincinnati 45229
(513) 636-4261 (Phone)
Certifications:
Anatomic Pathology, 1985, Pediatric Pathology, 1991
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Cincinnati / Main Campus
Graduated: 1979
St Louis Chldns Hosp
Washington University
Childrens Hospital Medical Center
University of Cincinnati / Main Campus
Graduated: 1979
St Louis Chldns Hosp
Washington University
Childrens Hospital Medical Center
Director Department Of Pathology At Cincinnati Childrens Hospital Medical Center
Position:
Director Department of Pathology at Cincinnati Childrens Hospital Medical Center
Location:
Cincinnati Area
Industry:
Hospital & Health Care
Work:
Cincinnati Childrens Hospital Medical Center
-
Director Department of Pathology
Quantitative Epstein Barr Virus Pcr Rapid Assay
US Patent:
6790952, Sep 14, 2004
Filed:
Feb 13, 2002
Appl. No.:
10/074620
Inventors:
Pamela A. Groen - Cincinnati OH
David P. Witte - Cincinnati OH
David P. Witte - Cincinnati OH
Assignee:
Cincinnati Childrens Hospital Research Foundation - Cincinnati OH
International Classification:
C07H 2100
US Classification:
536 2433, 536 243, 536 2432, 536 231, 536 2372, 435 4, 435 5, 435 6, 435 912
Abstract:
The present invention provides novel compositions comprising Epstein-Barr virus-specific oligonucleotides that are useful as primers to amplify particular regions of the genome during enzymatic nucleic acid amplification. The invention also provides a rapid, sensitive and specific method for the detection and quantitation of the virus which may be present in a clinical specimen, using the virus-specific primers and enzymatic nucleic acid amplification; hybridization of amplified target sequences, if present, with one or more Epstein-Barr virus-specific oligonucleotide probes which are labeled with a detectable moiety; and detection of the detectable moiety of labeled oligonucleotide probe hybridized to amplified target sequences of Epstein-Barr virus DNA.
Monophenotypic Xenograft Of Megakaryocytic Lineage And Origin
US Patent:
5147798, Sep 15, 1992
Filed:
Jul 5, 1991
Appl. No.:
7/727373
Inventors:
Beatrice C. Lampkin - Cincinnati OH
David P. Witte - Cincinnati OH
Richard E. Harris - Cincinnati OH
Michael A. Liebermann - Cincinnati OH
David P. Witte - Cincinnati OH
Richard E. Harris - Cincinnati OH
Michael A. Liebermann - Cincinnati OH
Assignee:
Children's Hospital Medical Center - Cincinnati OH
International Classification:
C12N 500, C12N 508, C12P 2102, C07K 1506
US Classification:
4352401
Abstract:
A continuous cell line of megakaryocytic origin is disclosed. This novel continuous cell line has been established in athymic nude mice. The cells of the established cell line monophenotypic for megakaryocytes is characterized as having multilobed nuclei and granular cytoplasm and being reactive for Factor VIII antigen, glycoprotein IIB-IIIa complex antigen and platelet peroxidase. The established cell line of this invention generates in isolatable quantities platelet-like factor IV, FGF-like,. beta. -thromboglobulin-like and TGF-. beta. -like growth factors. Methods for cultivating the established cell line, in a nude animal and isolating and purifying the proteins are also disclosed.
Quantitative Epstein Barr Virus Pcr Rapid Assay
US Patent:
2005015, Jul 14, 2005
Filed:
Aug 2, 2004
Appl. No.:
10/909641
Inventors:
Pamela Groen - Clarksville OH, US
David Witte - Cincinnati OH, US
David Witte - Cincinnati OH, US
International Classification:
C12Q001/70, C12Q001/68, C07H021/04
US Classification:
435005000, 435006000, 536023720
Abstract:
The present invention provides novel compositions comprising Epstein-Barr virus-specific oligonucleotides that are useful as primers to amplify particular regions of the genome during enzymatic nucleic acid amplification. The invention also provides a rapid, sensitive and specific method for the detection and quantitation of the virus which may be present in a clinical specimen, using the virus-specific primers and enzymatic nucleic acid amplification; hybridization of amplified target sequences, if present, with one or more Epstein-Barr virus-specific oligonucleotide probes which are labeled with a detectable moiety; and detection of the detectable moiety of labeled oligonucleotide probe hybridized to amplified target sequences of Epstein-Barr virus DNA.